Journal List > J Korean Med Sci > v.26(6) > 1021653

TOOLS
Park, Kwon, Hwang, Choi, Cho, Lee, and Yim: Impact of Visceral Adiposity Measured by Abdominal Computed Tomography on Pulmonary Function
Original Article
Respiratory Diseases
Journal of Korean Medical Science

Journal of Korean Medical Science 2011; 26(6): 771-777.

Published online: 18 May 2011

DOI: https://doi.org/10.3346/jkms.2011.26.6.771

Impact of Visceral Adiposity Measured by Abdominal Computed Tomography on Pulmonary Function

Young Sik Park1, Hyuk Tae Kwon2, Seung-Sik Hwang3, Seung Ho Choi4, Young Min Cho1, Jinwoo Lee1, Jae-Joon Yim1

1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

2Department of Family Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.

3Department of Social and Preventive Medicine, Inha University School of Medicine, Incheon, Korea.

4Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.

Address for Correspondence: Hyuk Tae Kwon, MD. Department of Family Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, 152 Teheran-ro, Gangnam-gu, Seoul 135-984, Korea. Tel: +82.2-2112-5745, Fax: +82.2-2112-5635, hyuktae@gmail.com

Received 26 January 2011       Accepted 29 March 2011

© 2011 The Korean Academy of Medical Sciences.

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Although an inverse relationship between abdominal adiposity and pulmonary function has been suggested, direct measurement of abdominal adipose tissue has rarely been attempted. Our object is to determine the impact of abdominal adiposity on pulmonary function by directly measuring abdominal adipose tissue with abdominal computed tomography (CT). In this cross-sectional study, we included never-smokers between the ages of 18 and 85 yr, who had undergone spirometry and abdominal adipose tissue analysis with CT scans during November 1, 2005 to October 31, 2009 as part of the comprehensive health examination. Among a total of 3,469 participants, 890 (25.7%) were male. The mean body mass index and waist circumference among males and females were 24.6 kg/m2 and 87.8 cm and 23.0 kg/m2 and 83.0 cm, respectively. Although total adipose tissue (TAT) of the abdomen in males (269.1 cm2) was similar to that in females (273.6 cm2), the ratio of visceral adipose tissue (VAT)/subcutaneous adipose tissue (SAT) was different; 0.99 in males and 0.50 in females. In males, TAT, SAT, and VAT were inversely associated with the absolute value of forced vital capacity (FVC), and TAT and VAT were inversely associated with forced expiratory volume in one second (FEV1). However, in females, TAT and VAT, but not SAT, were inversely associated with absolute FVC and FEV1 values. In conclusion, the amount of abdominal adipose tissue directly measured using CT is inversely associated with lung function.

Keywords: Obesity, Intra-Abdominal Fat, Pulmonary function, CT scan

INTRODUCTION

According to a 2008 World Health Organization report, more than 500 million adults globally were obese (1). Obesity is associated with many health-related problems, such as cardiovascular, metabolic, and respiratory system problems (2). Obesity, especially abdominal obesity, is suggested to be associated with decreased pulmonary function. Several researchers have reported that abdominal obesity is inversely associated with forced expiratory volume in 1 cecond (FEV1) and forced vital capacity (FVC) (3). Because direct measuring of abdominal fat distribution is practically difficult, body mass index (BMI), waist circumference (WC) (4, 5), waist/hip ratio (6) and abdominal height (3) have been used as surrogates for abdominal adiposity. However the association between these surrogates and pulmonary function has not been consistent among studies.
Anatomically, abdominal adiposity is composed of two different compartments; visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). VAT is metabolically more active and produces more pro-inflammatory adipokines than SAT (7). VAT is closely related to metabolic derangement, such as dyslipidemia (8), insulin resistance (9) and type 2 diabetes (7). Although an inverse relationship between abdominal adiposity and pulmonary function has been suggested, it is unclear which compartment is more closely related with pulmonary function. Only a few studies with small numbers of participants have investigated the relationship between compartments of abdominal adiposity and pulmonary function. Magnetic resonance imaging (10) and dual-energy radiography absorptiometry (11) have been performed to directly measure fat distribution in recent studies, but only a small number of subjects were enrolled.
We attempted to identify the impact of abdominal adiposity on pulmonary function by directly measuring the amount of abdominal adipose tissue using axial image post-processing from abdominal computed tomography (CT).

MATERIALS AND METHODS

Study population

In this cross-sectional study, we assessed study subjects between ages 18 to 85 yr who received comprehensive health examinations during November 1, 2005 to October 31, 2009, which included spirometry and abdominal adipose tissue analysis by CT scan. The examinations took place at the Healthcare System Gangnam Center (HCSGC) and Health Promotion/Disease Prevention Center (HPDPC) of Seoul National University Hospital, Seoul, Republic of Korea. Among them, we included only never smokers and excluded subjects with history of malignant diseases, self-reported asthma, and chronic lung diseases.

Measurements

Never-smokers were selected based on a self-administered medical questionnaire. Anthropometric measurements such as blood pressure (BP), height, weight, and WC were retrieved from the database, and BMI was calculated as weight in kilograms divided by the square of the height in meters (kg/m2). The population with BMI ≥ 23 kg/m2 was considered as overweight (12). WC was measured at the WHO recommended site; the midpoint between the lower border of the rib cage and the iliac crest (13). Results of blood tests including fasting plasma glucose (FPG), serum lipids, serum insulin and high-sensitivity C-reactive protein (hs-CRP) after overnight fasting were also collected.
Insulin resistance was assessed by the homeostatic model assessment of insulin resistance (HOMA-IR) (14). The formula for HOMA-IR is:
HOMA-IR=Fasting insulinµU/mL×Fasting glucosemM/L22.5jkms-26-771-e001
Low-density lipoprotein (LDL) cholesterol was measured directly. If directly measured LDL cholesterol was unavailable, LDL cholesterol was calculated (15). We excluded participants without directly measured LDL cholesterol level only when their triglycerides (TG) levels were above 400 mg/dL, since the estimated LDL cholesterol is not valid when the TG level is above 400 mg/dL.
Detailed methods of using abdominal CT cross-sectional images to measure abdominal adipose tissue area are described elsewhere (16). Briefly, subjects underwent 16-detector row CT imaging of the abdomen (Somatom Sensation 16, Siemens Medical Solutions, Forchheim, Germany) in a supine position with both arms stretched above the head. A single slice at the umbilicus level was obtained. The adipose tissue area was determined using commercially available CT software (Rapidia 2.8; INFINITT, Seoul, Korea), and visceral and subcutaneous adipose tissue boundaries were defined using a manual tracing method with a cursor (Fig. 1).
Spirometric tests were performed following the American Thoracic Society recommendations (17) and were taken by experienced technicians. The same type of dry rolling seal spirometer (Model 2130, Viasys Respiratory Care Inc., San Diego, CA, USA) was used in both centers. FVC, FEV1, and FEV1/FVC were measured, which were expressed both as absolute values (L) and predicted values (%), calculated from the formula based on Korean population (18).

Statistical analysis

We established multiple linear regression models to predict FVC and FEV1 from abdominal adiposity. Because the distribution of abdominal adipose tissue was significantly different for males and females, we calculated P value and adjusted R2 values separately according to gender. Model 1 was adjusted for age and height. Model 2 was adjusted for the components of Model 1 and metabolic components such as weight, WC, systolic BP, HOMA-IR, hs-CRP, and LDL cholesterol were added. Stata 10 (StataCorp, College Station, TX, USA) was used as the statistical software, and results were significant when P < 0.05.

Ethics statement

The protocol was approved by the institutional review board of the Seoul National University Hospital (H-0909-016-294). The board waived informed consent from participants. The study was conducted in accordance with the Declaration of Helsinki.

RESULTS

Demographic and clinical characteristics of the participants

Of the 7,113 participants who underwent health examinations including spirometry and abdominal adipose tissue analysis during the study period, 3,469 met our inclusion criteria (Fig. 2). Of the 3,469 participants, 890 (25.7%) were male. The mean BMI and WC among males and females were 24.6 ± 2.8 kg/m2 and 87.8 ± 7.8 cm and 23.0 ± 3.0 kg/m2 and 83.0 ± 8.3 cm, respectively. The overweight population was 648 (72.8%) in male, and 1,210 (46.9%) in female. Although TAT in males (269.1 ± 99.3 cm2) was similar to that in females (273.6 ± 97.3 cm2), the distribution of fat was different: the VAT/SAT ratio was 0.99 ± 0.38 in males and 0.50 ± 0.23 in females. The predicted FVC and FEV1 were 88.4 ± 11.2% and 113.8% ± 13.8% in males and 90.1% ± 11.4% and 111.5% ± 14.0% in females. The average FEV1/FVC in males and females was 81.3% ± 6.7% and 82.4% ± 6.4%, respectively (Table 1).

Association between abdominal fat and FVC

In males, TAT, SAT, and VAT were inversely associated with the absolute value of FVC, regardless of model. However, in females, SAT was not associated with FVC in either model 1 or 2. Instead, TAT and VAT in model 2, but not in model 1, were inversely associated with the absolute FVC value (Table 2).

Association between abdominal fat and FEV1

TAT, SAT, and VAT were also inversely associated with the absolute value of FEV1 in model 1 in males. However, the inverse association between SAT and FEV1 was attenuated in model 2 (P = 0.056). In females, VAT in model 1 and TAT and VAT in model 2 was inversely associated with FEV1, but there was no association between SAT and FEV1 in both model 1 and model 2 (Table 2).

Association between abdominal fat and predicted values of FVC and FEV1

Fig. 3 shows the scatter plots of predicted values of FVC and FEV1 according to the amount of visceral adipose tissue in overweight population (BMI ≥ 23 kg/m2). Both predicted FVC and FEV1 had statistically significant negative linear correlations with VAT. In normal BMI group (18.5 ≤ BMI < 23), only FVC showed negative linear correlation with VAT (P = 0.001 in male, P = 0.002 in female).

Correlation between WC, BMI and the amount of adipose tissue measured by CT

Table 3 shows the adjusted R2 between traditional abdominal adiposity indices and the amount of adipose tissue directly measured by abdomen CT. WC was best correlated with TAT (adjusted R2 = 0.775, P < 0.001 in male, and adjusted R2 = 0.701, P < 0.001 in female). And the similar result was observed with BMI and TAT (adjusted R2 = 0.672, P < 0.001 in male, and adjusted R2 = 0.649, P < 0.001 in female).

DISCUSSION

In our study, the amount of adipose tissue, TAT, SAT, or VAT, directly measured using abdominal CT was inversely associated with lung function among non-smokers, even after being adjusted for age, height, weight, WC, systolic BP, HOMA-IR, hs-CRP, and LDL cholesterol. This observation implies that the amount of adipose tissue has a negative impact on pulmonary function even after adjustment for anthropometric and metabolic parameters.
How the amount of adipose tissue affects pulmonary function is still unclear. One possible explanation is that the systemic inflammation triggered by adipose tissue. Adipose tissue is associated with elevated pro-inflammatory molecules, such as complement C3, tumor necrosis factor-α, and interleukin (IL)-6 (7). In addition, activated macrophages in adipose tissue cause low-grade chronic inflammation (19) and are associated with insulin resistance (20, 21) in animal models. Furthermore, IL-6, produced mainly from VAT in individuals with obesity, is related to CRP level in arterial blood (22). An animal study has shown that IL-6 overexpression may cause an emphysematous lung phenotype (23). In epidemiologic studies, elevated CRP or IL-6 was associated with chronic inflammatory airway disease, such as asthma (24) or chronic obstructive pulmonary disorder (COPD) (25). According to a recently published observational study, systemic inflammation was associated with reduced pulmonary function in never smoking male population (26). Considering these in vitro and in vivo observations, impaired pulmonary function among individuals with increased amount of adipose tissue could be understood in the context of systemic inflammation.
Traditionally, BMI and WC have been used as indices of abdominal adiposity. We directly compared the correlation between these surrogate indicators of abdominal adiposity and directly measured VAT, which is a metabolically active adipose tissue. In our study, WC and BMI were best correlated with TAT, and least correlated with VAT (Table 3). These phenomenon was also observed previously in Japanese population (27). In the context of the consistent results, WC and BMI could well reflect the amount of TAT, but not VAT.
Interestingly, the association between abdominal obesity and lung function was different in gender according to fat distribution. Compared between VAT and SAT, both were important in males, but only VAT was important in females (Table 2). In fact, there were several reports underscoring the importance of VAT as a metabolic risk among females rather than males. A cardiometabolic risk profile was associated with VAT more profoundly among females (28). In addition, the association between VAT and atherosclerosis was stronger in females than males (29). Our current study also coincided in the importance of VAT on pulmonary function among females. However, the reasons for the more profound decreased pulmonary function of VAT among females remain to be discovered.
Strength of our study is that we included only never-smokers. Previous or current smoking is one of the most important confounding factors affecting impaired pulmonary function. To eliminate any influence of smoking, we excluded patients with even minimal history of smoking. Subsequently, inclusion of patients with COPD was minimized.
However, to fully appreciate the results, we must consider the limitations of this study. First, the study participants were not representative of the general population. Participants in our study were those individuals who had undergone medical examinations consisting of rather expensive tests. These subjects might be more concerned about their health and could afford to pay the cost of the program. Therefore, a relatively healthier and wealthier group compared to the general population was included in this study. Second, because this was a cross-sectional study, we could not infer a cause and effect relationship between abdominal obesity and decreased lung function. To confirm the causality of abdominal obesity on pulmonary function, an individualized follow up study is needed.
In conclusion, the amount of abdominal adipose tissue directly measured using CT is inversely associated with lung function. However, the amount of TAT is more important for pulmonary function in males, but the amount of VAT rather than SAT is more important in females.

Figures and Tables

Fig. 1
The measurement of abdominal adiposity using CT imaging of the abdomen. Visceral adipose tissue area (A) and total adipose tissue area (B) were measured using CT image of the abdomen at the umbilicus level.
jkms-26-771-g001
Fig. 2
Participants in this study. *Healthcare System Gangnam Center; †Health Promotion/Disease Prevention Center.
jkms-26-771-g002
Fig. 3
Scatter plot of predicted forced vital capacity (FVC % pred.) and predicted forced expiratory volume in 1 sec (FEV1 % pred.) according to the amount of visceral adipose tissue in overweight population (BMI > 23 kg/m2). Both predicted FVC (%) (A, B) and FEV1 (%) (C, D) show negative correlation with the amount of visceral adipose tissue.
jkms-26-771-g003
Table 1
Baseline characteristics of the participants
jkms-26-771-i001

Values are given as the mean ± SD. BMI, body mass index; HOMA-IR, homeostatic model assessment of insulin resistance; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; TAT, total adipose tissue; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.

Table 2
Multiple linear regression models to predict forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) from abdominal adipose tissue amount
jkms-26-771-i002

*Model 1 was adjusted for age and height; †Model 2 was adjusted for age, height, weight, waist circumference, systolic blood pressure, homeostatic model assessment of insulin resistance, high-sensitivity C-reactive protein and low-density lipoprotein cholesterol. TAT, total adipose tissue; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.

Table 3
The results of adjusted R2 in linear regression between WC, BMI and the amount of adipose tissue measured by CT
jkms-26-771-i003

All the values were P < 0.001. WC, waist circumference; BMI, body mass index (kg/m2); TAT, total adipose tissue; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.

Notes

All authors have no conflict of interest to disclose.

AUTHOR SUMMARY

Impact of Visceral Adiposity Measured by Abdominal Computed Tomography on Pulmonary Function
Young Sik Park, Hyuk Tae Kwon, Seung-Sik Hwang, Seung Ho Choi, Young Min Cho, Jinwoo Lee and Jae-Joon Yim
Although an inverse relationship between abdominal adiposity and pulmonary function has been suggested, direct measurements of abdominal adipose tissue have been attempted only rarely. Through cross-sectional study analyzing 3,469 never-smokers, we confirmed that the amount of abdominal adipose tissue directly measured using CT was inversely associated with lung function, and this tendency showed gender-difference. The amount of total adipose tissue is more important for pulmonary function in males, but the amount of visceral adipose tissue rather than subcutaneous adipose tissue is more important in females.

References

1. Obesity and overweight. Fact sheet No. 311. World Health Organization. accessed on 18 Mar 2011. Available at http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
2. McClean KM, Kee F, Young IS, Elborn JS. Obesity and the lung. 1. Epidemiology. Thorax. 2008. 63:649–654.
3. Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Trevisan M, Cassano PA, Iacoviello L, Schünemann HJ. Pulmonary function and abdominal adiposity in the general population. Chest. 2006. 129:853–862.
4. Chen Y, Rennie D, Cormier YF, Dosman J. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr. 2007. 85:35–39.
5. Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, Guize L, Zureik M. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med. 2009. 179:509–516.
6. Zavorsky GS, Murias JM, Kim DJ, Gow J, Sylvestre JL, Christou NV. Waist-to-hip ratio is associated with pulmonary gas exchange in the morbidly obese. Chest. 2007. 131:362–367.
7. Samaras K, Botelho NK, Chisholm DJ, Lord RV. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity (Silver Spring). 2010. 18:884–889.
8. Oka R, Miura K, Sakurai M, Nakamura K, Yagi K, Miyamoto S, Moriuchi T, Mabuchi H, Koizumi J, Nomura H, Takeda Y, Inazu A, Nohara A, Kawashiri MA, Nagasawa S, Kobayashi J, Yamagishi M. Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese. Obesity (Silver Spring). 2010. 18:153–160.
9. Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, Irlbeck T, Meigs JB, Sutherland P, D'Agostino RB Sr, O'Donnell CJ, Fox CS. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring). 2010. 18:2191–2198.
10. Babb TG, Wyrick BL, DeLorey DS, Chase PJ, Feng MY. Fat distribution and end-expiratory lung volume in lean and obese men and women. Chest. 2008. 134:704–711.
11. Sutherland TJ, Goulding A, Grant AM, Cowan JO, Williamson A, Williams SM, Skinner MA, Taylor DR. The effect of adiposity measured by dual-energy X-ray absorptiometry on lung function. Eur Respir J. 2008. 32:85–91.
12. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. 2000. International Obesity Task Force.
13. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000. 894:i–xii. 1–253.
14. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 1997. 20:1087–1092.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972. 18:499–502.
16. Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, Song IS. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut. 2008. 57:1360–1365.
17. American Thoracic Society. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995. 152:1107–1136.
18. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis. 2005. 58:230–242.
19. Suganami T, Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol. 2010. 88:33–39.
20. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003. 112:1796–1808.
21. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003. 112:1821–1830.
22. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007. 56:1010–1013.
23. Kuhn C 3rd, Homer RJ, Zhu Z, Ward N, Flavell RA, Geba GP, Elias JA. Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Cell Mol Biol. 2000. 22:289–295.
24. Neveu WA, Allard JL, Raymond DM, Bourassa LM, Burns SM, Bunn JY, Irvin CG, Kaminsky DA, Rincon M. Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function. Respir Res. 2010. 11:28.
25. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999. 160:1856–1861.
26. Lim SY, Rhee EJ, Sung KC. Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males. J Korean Med Sci. 2010. 25:1480–1486.
27. Oka R, Miura K, Sakurai M, Nakamura K, Yagi K, Miyamoto S, Moriuchi T, Mabuchi H, Yamagishi M, Takeda Y, Hifumi S, Inazu A, Nohara A, Kawashiri MA, Kobayashi J. Comparison of waist circumference with body mass index for predicting abdominal adipose tissue. Diabetes Res Clin Pract. 2009. 83:100–105.
28. He H, Ni Y, Chen J, Zhao Z, Zhong J, Liu D, Yan Z, Zhang W, Zhu Z. Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl Res. 2010. 155:71–77.
29. Ditomasso D, Carnethon MR, Wright CM, Allison MA. The associations between visceral fat and calcified atherosclerosis are stronger in women than men. Atherosclerosis. 2010. 208:531–536.
TOOLS
Similar articles